These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23911560)

  • 41. Pretherapeutic staging of locally advanced cervical cancer: Inframesenteric paraaortic lymphadenectomy accuracy to detect paraaortic metastases in comparison with infrarenal paraaortic lymphadenectomy.
    Azaïs H; Ghesquière L; Petitnicolas C; Borghesi Y; Tresch-Bruneel E; Cordoba A; Narducci F; Bresson L; Leblanc E
    Gynecol Oncol; 2017 Nov; 147(2):340-344. PubMed ID: 28919265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings.
    Lin WC; Hung YC; Yeh LS; Kao CH; Yen RF; Shen YY
    Gynecol Oncol; 2003 Apr; 89(1):73-6. PubMed ID: 12694656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
    Martinez A; Voglimacci M; Lusque A; Ducassou A; Gladieff L; Dupuis N; Angeles MA; Martinez C; Tanguy Le Gac Y; Chantalat E; Hitzel A; Courbon F; Ferron G; Gabiache E
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1252-1260. PubMed ID: 31915897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial.
    Köhler C; Mustea A; Marnitz S; Schneider A; Chiantera V; Ulrich U; Scharf JP; Martus P; Vieira MA; Tsunoda A
    Am J Obstet Gynecol; 2015 Oct; 213(4):503.e1-7. PubMed ID: 25986030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.
    Grigsby PW; Siegel BA; Dehdashti F
    J Clin Oncol; 2001 Sep; 19(17):3745-9. PubMed ID: 11533097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laparoscopic Extraperitoneal Pelvic Lymph Node Debulking in Locally Advanced Cervical Cancer.
    Diaz-Feijoo B; Luna-Guibourg R; Cabrera S; Manrique S; Gil-Moreno A
    J Minim Invasive Gynecol; 2019 Feb; 26(2):366. PubMed ID: 29783001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retroperitoneal Laparoscopic Para-Aortic Lymphadenectomy in Para-Aortic Staging of Locally Advanced Cervical Cancer.
    Vázquez-Vicente D; Fernández Del Bas B; García Villayzán J; Plaza Arranz J; Chiva L
    J Minim Invasive Gynecol; 2018; 25(7):1142-1143. PubMed ID: 29427781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Para-aortic workup in locally advanced cervical cancer: heterogeneity is still the rule. Results from a retrospective multicenter study.
    Chantalat E; Vidal F; Leguevaque P; Lepage B; Lambaudie E; Hebert T; Motton S
    Arch Gynecol Obstet; 2016 May; 293(5):1081-6. PubMed ID: 26385726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of pelvic and para-aortic lymphadenectomy versus para-aortic lymphadenectomy alone for locally advanced FIGO stage IB2 to IIB cervical cancer using a propensity score matching analysis: Results from the FRANCOGYN study group.
    Bendifallah S; de Foucher T; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Huguet F; Graesslin O; Touboul C; Collinet P; Huchon C; Daraï E; Ballester M;
    Eur J Surg Oncol; 2018 Dec; 44(12):1921-1928. PubMed ID: 30213717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Lymph node surgical staging for locally advanced cervical cancer].
    Delpech Y; Tulpin L; Bricou A; Barranger E
    Gynecol Obstet Fertil; 2010 Jan; 38(1):30-5. PubMed ID: 20022794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Para-aortic plus pelvic lymphadenectomy in locally advanced cervical cancer: A single institutional experience.
    Mezquita G; Muruzabal JC; Perez B; Aguirre S; Villafranca E; Jurado M
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():79-83. PubMed ID: 30889424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer.
    Houvenaeghel G; Lelievre L; Rigouard AL; Buttarelli M; Jacquemier J; Viens P; Gonzague-Casabianca L
    Gynecol Oncol; 2006 Jul; 102(1):74-9. PubMed ID: 16406062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The indication and surgery scope for laparoscopic extraperitoneal lymphadenectomy in locally advanced cervical cancer].
    Zhong ML; Liang MR; Jiang W; Wang YN; Zeng Y; Zeng SY
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):303-308. PubMed ID: 31014057
    [No Abstract]   [Full Text] [Related]  

  • 54. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
    Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
    Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implications of extraperitoneal paraaortic lymphadenectomy to the left renal vein in locally advanced cervical cancer. A Spanish multicenter study.
    Díaz-Feijoo B; Franco S; Torné A; Benito V; Hernández A; Lago V; Rovira R; Acosta Ú; Agustí N; Gil-Moreno A;
    Gynecol Oncol; 2020 Aug; 158(2):287-293. PubMed ID: 32467055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patients with locally advanced cervical cancer should not undergo routine pretreatment surgical staging.
    Mota F; De Oliveira C
    Eur J Gynaecol Oncol; 2006; 27(2):109-14. PubMed ID: 16620049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selection of patients with advanced-stage cervical cancer for para-aortic lymphadenectomy in the era of PET/CT.
    Margulies AL; Peres A; Barranger E; Perreti I; Brouland JF; Toubet E; Sarda-Mantel LE; Thoury A; Chis C; Walker F; Luton D; Delpech Y; Koskas M
    Anticancer Res; 2013 Jan; 33(1):283-6. PubMed ID: 23267158
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
    Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
    Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
    Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.